Potential anti-obesity and lipid lowering natural products: A review

Natural Product Communications

Volumn 2, Issue 3, 2007, Pages 331-348

  Bhutani, Kamlesh Kumar ^a   Birari, Rahul ^a   Kapat, Kausik ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Anti obesity; Hyperlipidemia; Lipid; Natural products; Plant extracts

Indexed keywords

EID: 35148852985     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0700200316     Document Type: Review

References (106)

1. Cairns E. (2005) Obesity: the fat lady sings? Drug Discovery Today, 10, 305-307.
2. http://www.who.int/mediaeentre/news/releases/2005/pr44/en/index.html
3. Melnikova I, Wages D. (2006) Antiobesity therapies. Nature Reviews: Drug Discovery, 5, 369-370.
4. Strader CD, Hwa JJ, Heek M.V., Parker EM (1998) Novel molecular targets for the treatment of obesity. Drug Discovery Today, 3, 250-256.
5. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/
6. Marcini MC, Halpern A. (2006) Pharmacological treatment of obesity. Arquivos Brasileiros de Endocrinologia and Melabologia, 50, 377-389.
7. Weigle DS. (2003) Pharmacological therapy of obesity: Past, present, and future. The Journal of Clinical Endocrinology and Metabolism, 88, 2462-2469.
8. Mancini MC, Halpern A. (2006) Investigational therapies in the treatment of obesity. Expert Opinion in Investigational Drugs, 15, 897-915.
9. Halford JC. (2006) Obesity drugs in clinical development. Current Opinion in Investigational Drugs, 7, 312-318.
10. Jandacek RJ, Woods SC (2004) Pharmaceutical approaches to the treatment of obesity. Drug Discovery Today, 9, 874-880.
11. Bray GA, Tartaglia LA (2000) Medicinal strategies in the treatment of obesity. Nature, 404, 672-677.
12. Paranjpe P, Patki P, Patwardhan B. (1990) Ayurvedic treatment of obesity: Randomized, double-blind, placebo-controlled clinical trial. Journal of Ethnopharmacology, 29, 1-11.
13. Saper RB, Eisenberg DM, Philips RS (2004) Common dietary supplements for weight loss. American Family Physician, 70, 1731-1738.
14. Tiwari AK, Rao M. (2002) Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Current Science, 83, 30-38.
15. Bent S, Tiedt TN, Odden M.C., Shlipak MG (2003) The relative safety of ephedra compared with other herbal products. Annals of Internal Medicine, 138, 468-471.
16. Hadvaty P, Lengsfeld H, Wolfer H. (1988) Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. The Biochemical Journal, 256, 357-361.
17. Moreno DA, Ilic N, Pouley A., Brasaemle DL, Fried SK, Raskin I. (2003) Inhibitory effects of grape seed extract on lipases. Nutrition, 19, 876-879.
18. Han LK, Takaku T, Li J., Kimura Y, Okuda H. (1999) Anti-obesity action of oolong tea. International Journal of Obesity, 23, 98-105.
19. Han LK, Kimura Y, Kawashima M., Takaku T, Taniyama T, Tayashi T., Zeng YN, Okuda H. (2001) Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Internationaljournal of Obesity, 25, 1459-1464.
20. Nakai M, Fukui Y, Asami S., Toyoda-Ono Y, Iwashita T, Shibata H., Mitsunaga T, Hashimoto F, Kiso Y. (2005) Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. Journal of Agricultural and Food Chemistry 53 4593-4598.
21. Han LK, Xu BJ, Kimura Y, Zheng Y., Okuda H. (2000) Platycodi Radix affects lipid metabolism in mice with fat diet-induced obesity. Journal of Nutrition, 130, 2760-2764.
22. Han LK, Xu BJ, Zheng Y Kimura Y, (2002) Saponins from platycodi Radix amellorate high fat diet-induced obesity in mice. Journal of Nutrition 132, 2241-2245
23. Zao HL, Kim YS (2002) Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglycende-based colorimetnc assay. Archives of Pharmacol Research, 25, 446-448.
24. Xu BJ, Han LK, Zheng Y.N., Lee JH, Sung CK (2005) In Vitro inhibitory effect of triterpenoidal saponins from Platycodi Radix o, pancreatic lipase. Archives of Pharmacol Research, 28, 180-185.
25. Zhao HL, Sim JS Shim SH, Ha YW Rang SS Kim YS. (2005) Antiobese and hypolipidemic effects of platycodin saponins ir diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction. International Journal of Obesity, 29, 983-990.
26. Lee IA, Lee JH, Baek N.I., Kim DH (2005) Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin. Biological and Pharmaceutical Bulletin, 28, 2106-2110.
27. Yamamota M, Shimura S, Itoh Y., Ohsaka T, Egawa M, Inoue S. (2000) Anti-obesity effects of lipase inhibitor CT-II an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. International Journal of Obesity, 24, 758-764
28. Hatano T, Yamashita A, Hashimoto T., Ito H, Kubo N, Yoshiyama M., Shimura S, Itoh Y, Okuda T, Yoshida T (1997) Flavan dimers with lipase inhibitory activity from Cassia nomame. Phytochemisny, 46, 893-900.
29. Ninomiya K, Matsuda H, Shimoda H., Nishida N, Kasajima N, Yoshino T., Morikawa T, Yoshikawa M. (2004) Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorganic and Medicinal Chemistry Letters, 14, 1943-1945.
30. Moreno DA, Ilic N, Pouley A., Raskin I. (2006) Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Life Sciences, 78, 2797-2803.
31. Zheng Q, Koike K, Han L.K., Okuda H., Nikaido T. (2004) New biologically active triterpenoid saponins from Scabiosa tschiliensh Journal of Natural Products, 67, 604-613.
32. Masayuki Y, Hiroshi S, Nirihisa N., Miki T, Hisashi M. (2002) Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lypophilic activities have mild antiobesity effects in rats. Journal of Nutrition, 132, 1819-1834.
33. Yoshizumi K, Hirano K, Ando H., Hirai H, Ida Y, Tsuji T., Tanaka T, Satouchi K, Terao J. (2006) Lupane type saponins from leaves of Acanthopanax sessiliflorus and their inhibitory activity on pancreatic lipase. Journal of Agriculture and Food Chemistry, 54, 335-341.
34. Han LK, Zheng YN, Yoshikawa M. Okuda H, Kimura Y. (2005) Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complementary and Alternative Medicine, 5, 9-18.
35. Shin JE, Han MJ, Kim DH (2002) 3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lioase Binlogical and Pharmaceutical Bulletin, 25, 1442-1445.
36. Shin JE, Han MJ, Song M.C., Baek NI, Kim DH (2004) 5-Hydroxy-7-(4'- hydroxy-3-methoxyphenyl)-l-phenyl-3-heptanone: A pancreatic lipase inhibitor isolated from Alpinia officinarum. Biological and Pharmaceutical Bulletin, 27 138-140
37. Han LK, Li DX, Xiang L, Gong X.J., Kondo Y., Suzuki I, Okuda H. (2006) Isolation of pancreatic lipase inhibitor component of Spirulina platensis and it reduce postprandial triacylglycerolemia, Yakugaku Zasshi, 126, 43-49.
38. Young KH, Hui KM (2005) Screening of Korean medicinal plants for lipase inhibitory activity. Phytotherapy Research 19, 359-361.
39. Sharma N, Sharma V, Seo S. (2005) Screening of some medicinal plants for anti-lipase activity. Journal of Ethnopharmacology, 97, 453-456.
40. Slanc P, Doljak B, Mlinaric A., Stuklj B. (2004) Screening of wood damaging fungi and macrofungi for inhibitors of pancreatic lipase. Phytotherapy Research, 18, 758-762.
41. Chen HC, Farese RV (2005) Inhibition of triglyceride synthesis as a treatment strategy for obesity lessons from DGAT1-deficient mice. Arteriosclerosis Thrombosis and Vascular Biology, 25, 482-486.
42. Chung MY Rho MC, Lee SW Park HR Kim K Lee IA, Dong. (2006) Inhibition of diacylglycerol acyltransferase by betulinic acid from Almis hirsuta. Planta Medico, 72, 267-269.
43. Chung MY, Rho MC, Ko J.S., Ryu SY Jeune KH, Kim K, Lee HS, Kim YK. (2004) In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Medico, 70, 258-260.
44. Ko JS, Rho MC, Chung MY Song HY Rang JS, Kim K Lee HS Kim YK. (2002) Quinolone alkaloids, diacylglyeerol acyltransferase inhibitors from the fruits of Evodia rutaecarpa. Planta Medica, 68, 1131-1133.
45. Kobayashi Y, Nakano Y, Kizaki M., Hoshikuma K, Yokoo Y, Kamiya T. (2001) Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Medica, 67, 628-633.
46. Han LK, Sumiyoshi M, Zhang J., Liu MX, Zhang XF, Zheng YN, Okuda H, Kimura Y. (2003) Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals. Phytotherapy Research, 17, 1188-1194.
47. Han LK, Sumiyoshi M, Zheng Y.N., Okuda H., Kimura Y. (2003) Anti-obesity action of Salix matsudana leaves (Part 2). Isolation of anti-obesity effectors from polyphenol fractions of Salix matsudana. Phytotherapy Research, 17, 1195-1198.
48. Ko JS, Ryu SY, Kim Y.S., Chung MY, Kang JS, Rho MC, Lee H.S., Kim YK. (2002) Inhibitory activity of diacylglycerol acyltransferase by tanshinones from the root of Salvia miltiorrhiza. Archives of Pharmacol Research, 25, 446-448.
49. Haller CA, Jacob P, Benowitz NL (2004) Enhanced stimulant and metabolic effects of combined cphedrine and caffeine. Clinical Pharmacology and Therapeutics, 75, 259-273.
50. Preuss HG, Di Ferdinando D, Bagchi M, Bagchi D. (2002) Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. Journal of Medicine, 33, 247-264.
51. Berman A, Myers A. (2004) Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Experimental Biology and Medicine, 229, 698-704.
52. Chantre P, Lairon D. (2002) Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine, 9, 3-8.
53. Dulloo AG, Seydoux J, Girardier L., Chantre P, Vandermander J. (2000) Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. International Journal of Obesity and Related Metabolic Disorders, 24, 252-258.
54. Juhel C, Armand M, Pafumi Y., Rosier C, Vandermander J, Lairon D. (2000) Green tea extract (AR25®) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro - Effects on lipid metabolism and mechanism of action. Journal of Nutritional Biochemistry, 11, 45-51.
55. Asida H, Furuyashiki T, Nagayasu H., Bessho H, Sakakibara H, Hashimoto T., Kanazawa K. (2004) Anti-obesity actions of green tea: Possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. BioFactors, 22, 135-140.
56. Saito M, Ueno M, Ogino S., Kubo K, Nagata J, Takeuchi M. (2005) High dose of Garcinia cambogia is effective in suppressing fat accumulation in developing male Zucker obese rats, but highly toxic to the testis. Food and Chemical Toxicology, 43, 411-419.
57. Ohia S, Opère C, LeDay A., Bagchi M, Bagchi D, Stohs SJ (2002) Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Molecular and Cellular Biochemistry, 238, 89-103.
58. Koshy AS, Anila L, Vijayalakshmi NR (2001) Flavonoids from Garcinia cambogia lower lipid levels in hypercholesterolemic rats. Food Chemistry, 72, 289-294.
59. Soni MG, Burdock GA, Preuss H.G., Stohs SJ, Ohia SE, Bagchi D. (2004) Safety assessment of (-) - hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt. Food Chemistry Toxicology, 42, 1513-1529.
60. Morimoto C, Satoh Y, Hara M., Inoue S, Tsujitae T, Okuda H. (2005) Anti-obese action of raspberry ketone. Life Sciences, 77, 194-204.
61. Castonguay TW, Bellinger LL (1987) Capsaicin and its effects upon meal patterns, and glucagon and epinephrine suppression of food intake. Physiology and Behavior, 40, 337-342.
62. Preuss HG, Bagchi D, Bagchi M., Rao CV, Dey DK, Satyanarayana S. (2004) Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes, Obesity and Metabolism, 6, 171-180.
63. Woodgate DE, Conquer JA (2003) Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: A six-week exploratory study. Current Therapeutic Research, 64, 248-262.
64. Walker EA, Stewart PM (2003) 11 Beta-hydroxystcroid dehydrogenase: unexpected connections. Trends in Endocrinology and Metabolism, 14, 334-339.
65. Li RS, Nakagawa Y, Nakanishi T., Fujisawa Y. (2004) Different responsiveness in body weight and hepatic 11 beta-hydroxysteroid dehydrogenase (11β-HSD) type 1 m-RNA to 11-beta-HSD inhibition by glycyrrhetinic acid treatment in obese and lean zucker rats. Metabolism, 53, 600-606.
66. Bordia A, Verma SK, Srivastava KC (1997) Effect of ginger (Zingiber officinale Rose.) and fenugreek (Trigonella foenum-graecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 56, 379-384.
67. Gebhardt R. (1993) Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids, 28, 613-619.
68. Liu L, Yeh YY (2000) Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic. Lipids, 35, 197-203.
69. Matsuura H. (2001) Saponins in garlic as modifiers of the risk of cardiovascular disease. Journal of Nutrition, 131, 10005-10055.
70. Satyavati GV. (1991) Guggulipid: a promising hypolipidemic agent from gum guggul (Commiphora wightii). Economic and Medicinal Plant Research, 5, 47-82.
71. Satyavati GV, Dwarakanath C, Tripathi SN (1969) Experimental studies on the hypocholesterolemic effect of Commiphora mukul. Engl (Guggul). Indian Journal of Medicinal Research, 57, 1950-1962.
72. Singh V, Kaul S, Chander R., Kapoor NK (1990) Stimulation of low density lipoprotein receptor activity in liver membrane of guggulsterone treated rats. Pharmacology Research, 22, 37-44.
73. Thompson JS, Ernst E. (2003) Herbs for serum cholesterol reduction: A systematic review. The Journal of Family Practice, 52, 468-478.
74. Nityanand S, Srivastava JS, Asthana OP (1989) Clinical trials with guggulipid: A new hypolipidaemic agent The Journal of the Association of Physicians of India, 37, 323-328.
75. Tripathi YB, Malhotra OP, Tripathi SN (1984) Thyroid stimulating action of Z-guggulsterone obtained from Commiphora mukul Planta Medica, 50, 78-80.
76. Panda S, Kar A. (1999) Gugulu (Commiphora mukul) induces triiodothyronine production: Possible involvement of lipid peroxidation. Life Sciences, 65, PL137-PL141.
77. Patil VD, Nayak UR, Sukhdev. (1972) Chemistry of Ayurvedic crude drugs-I Guggulu (resin from Commiphora mukul)-1: Steroidal constituents. Tetrahedron, 28, 2341-2352.
78. Patil VD, Nayak UR, Sukhdev. (1972) Chemistry of ayurvedic crude drugs-II Guggulu (resin from Commiphora mukuh-2: Diterpenoid constituents. Tetrahedron, 29, 341-348.
79. Zhu N, Rafi MM, DiPaola R.S., Xin J., Chin CK, Badmaev V, Ghai G, Rosen R.T., Ho CT. (2001) Bioactive constituents from gum guggul (Commiphora wightii). Phytochemistry, 56, 723-727.
80. Chander R, Khanna AK, Kapoor NK (1996) Lipid lowering activity of guggulsterone from Commiphora mukul in hyperlinaemic rats. Phytotherapy Research, 10, 508-511.
81. Urizar NL, Liverman AB, Dodds D.T., Silva FV, Ordentlich P, Yan Y, Gonzalez F.J., Heyman RA, Mangelsdorf DJ Moore DD (2002) A natural product that lowers cholesterol as an antagonist ligand for FXR. Science, 296, 1703-1706
82. Wu J, Xia C, Meier J., Li S, Hu X, Lala DS (2002) The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Molecular Endocrinology, 16, 1590-1597.
83. Bhandari U, Sharma JN, Zafar R. (1998) The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits. Journal of Ethnopharmacology, 61, 167-171.
84. Tanabe M, Chen YD, Saito K, Kano Y. (1993) Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe Chemical and Pharmaceutical Bulletin, 42, 710-713.
85. Han L, Gong XJ, Kawano S, Saito M., Kimura Y, Okuda H. (2005) Antiobesity actions of Zingiber officinale Roscoe Yakusaku Zasshi, 725, 213-217.
86. Babu PS, Srinivasan K. (1997) Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Molecular and Cellular Biochemistry, 166, 169-175.
87. Mathur R, Sharma A, Dixit, VP, Varma M. (1996) Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. Journal of Ethnopharmacology, 50, 61-68.
88. Anila L, Vijayalakshmi NR (2002) Flavonoids from Emblica officinalis and Mangifera indica - effectiveness for dyslipidemia Journal of Ethnopharmacology, 79, 81-87.
89. Rodriguez TS, Giménez DG, Vázquez RD. (2002) Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. Phytomedicine, 9, 687-693.
90. Gebhardt R. (2002) Prevention of taurolithocholate-induced hepatic bile canalicular distortions by HPLC-characterized extracts of artichoke (Cynara scolymus) leaves. Planta Medica, 68, 116-119.
91. Gebhardt R. (1998) Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L) extracts. The Journal of Pharmacology and Experimental Therapeutics, 286, 1122-1128.
92. Shimodaa H, Ninomiyaa K, Nishida N., Yoshino T, Morikawa T, Matsuda H., Yoshikawa M. (2003) Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorganic and Medicinal Chemistry Letters, 13, 223-228.
93. Turley SD, Dietschy JM (1995) Mechanisms of LDL-cholesterol lowering action of psyllium hydrophilic mucilloid in the hamster. Biochimica Biophysica Acta, 1255, 177-184.
94. Turley SD, Daggy BP, Dietschy JM (1991) Cholesterol-lowering action of psyllium mucilloid in the hamster: sites and possible mechanisms of action. Metabolism, 40, 1063-1073.
95. Rajendran S, Deepalakshmi PD, Parasakthy K, Devaraj H., Devaraj SN (1996) Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis, 123, 235-241.
96. Ram A, Lauria P, Gupta R., Kumar P, Sharma VN (1996) Hypocholesterolaemic effects of Terminaiia arjuna tree bark. Journal of Ethnopharmacology, 55, 165-169.
97. Shaila HP, Udupa SL, Udupa AL (1998) Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. International Journal of Cardiology, 67, 119-124.
98. Shukla R, Gupta S, Gambhir J.K., Prabhu KM, Murthy PS (2004) Antioxidant effect of aqueous extract of the bark of Ficus bengalensis in hypercholesterolaemic rabbits. Journal of Ethnopharmacology, 92, 47-51.
99. Ram A, Lauria P, Gupta R., Kumar P, Sharma VN (1996) Hypolipidaemic effects of Myristica fragrans fruit extract in rabbits. Journal of Ethnopharmacology, 55, 49-53.
100. Chu S, Qu W, Pang X., Sun B. (2003) Effect of saponin from Tributes terrestris on hyperlipidemia. Zhong Yao Cai, 26, 341-344.
101. 4 on pancreatic lipase activity and cholesterol accumulation within Caco-2 cells. Journal of Pharmacy and Pharmaceutical Science 5, 29-38.
102. Looije NA, Risovic V, Stewart D.J., Debeyer D., Kutney J, Wasan KM (2005) Disodium ascorbyl phytostanyl phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model. Journal of Pharmacy and Pharmaceutical Science, 8, 400-408.
103. Senanayake GVK, Maruyamaa M, Shibuya K., Sakono M, Fukuda N, Morishita T., Yukizaki C, Kawano M, Ohta H. (2004) The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. Journal of Ethnopharmacology, 91, 257-262.
104. Chaturvedi P, George S, Milinganyo M., Tripathi YB (2004) Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytotherapy Research, 18, 954-956.
105. Prince PSM, Menon VP, Gunasekaran G. (1999) Hypolipidaemic action of Tinospora cordifolia roots in alloxan diabetic rats. Journal of Ethnopharmacology, 64, 53-57.
106. Sharma SB, Nasir A, Prabhu K.M., Murthy PS, Murthy D. (2003) Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. Journal of Ethnopharmacology, 85, 201-206.